Science Careers Blog

September 30, 2008

Big R&D Job Cuts at GlaxoSmithKline

Reuters/International Herald Tribune and the Wall Street Journal (subscription required for WSJ access) are reporting that GlaxoSmithKline intends to cut 850 research and development (R&D) jobs in the United States and the United Kingdom--6% of Glaxo's R&D staff. These job cuts are on top of 350 announced earlier this year, meaning that Glaxo is eliminating 8+% of their R&D workforce.

blog comments powered by Disqus